Cargando…
Editorial: Therapies and influences in urothelial carcinoma
Autores principales: | Ozgun, G., Isharwal, S., Eigl, B. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834270/ https://www.ncbi.nlm.nih.gov/pubmed/36644640 http://dx.doi.org/10.3389/fonc.2022.1126494 |
Ejemplares similares
-
Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors
por: Lavoie, Jean-Michel, et al.
Publicado: (2021) -
Editorial: Optimal perioperative management of urothelial carcinoma
por: Holzman, Ariane, et al.
Publicado: (2023) -
Editorial: Recent Advances in Diagnosis and Management of Urothelial Carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2021) -
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
por: Lavoie, Jean-Michel, et al.
Publicado: (2022) -
Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)